CURIS, INC. Income Tax (Expense) Benefit, Continuing Operations, Government Grants
CURIS, INC. (CRIS) reported Income Tax (Expense) Benefit, Continuing Operations, Government Grants of $488.96 thousand for the 12-month period ending 2010-12-31, per its 10-K filed 2013-03-13.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefitContinuingOperationsGovernmentGrants · last filed 2013-03-13
- CURIS, INC. income tax (expense) benefit, continuing operations, government grants for fiscal 2010 was $488.96K.
| Period end | Income Tax (Expense) Benefit, Continuing Operations, Government Grants 12 month |
|---|---|
| 2010-12-31 | $488.96K 10-K · filed 2013-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |